Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alberto Farolfi
Resource Utilization and Cost Saving Analysis of Subcutaneous Versus Intravenous Trastuzumab in Early Breast Cancer Patients
Oncotarget
Oncology
Related publications
Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer
JAMA Oncology
Cancer Research
Oncology
Cost-Utility Analysis of Adjuvant Trastuzumab Therapy for HER2-positive Early-Stage Breast Cancer in the Philippines
BMC Health Services Research
Health Policy
Pcn75 - Budget Impact Model of Subcutaneous Trastuzumab Compared With Intravenous Trastuzumab on the Treatment of Her-2 Positive Breast Cancer in the Brazilian Private Healthcare System
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Cost of Comprehensive Patient Assistance Program in Early Breast Cancer Patients
SpringerPlus
Multidisciplinary
Cost Considerations in Determining the Affordability of Adjuvant Trastuzumab in Breast Cancer
South African Medical Journal
Medicine
Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study
Oncologist
Cancer Research
Medicine
Oncology
Pcn74 - A Budget-Impact Analysis of Adjuvant Pertuzumab and Trastuzumab in Early Her2-Positive Breast Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
